Circulating plasma miRNA-21 as a superior biomarker compared to CA 15-3: Assessment in healthy age matched subjects and different stage of breast cancer patients
Research output: Contribution to journal › Article › peer-review
13Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Circulating plasma miRNA-21 as a superior biomarker compared to CA 15-3: Assessment in healthy age matched subjects and different stage of breast cancer patients'. Together they form a unique fingerprint.